Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 —— 资产负债表 (NASDAQ:SILO)

Financials

总资产 1.43 M10.49 M11.64 M7.75 M7.41 M7.61 M 负债总额 145.97 K1.43 M1.3 M1.57 M2.38 M1.3 M 权益总额 1.28 M9.06 M10.34 M6.18 M5.03 M6.31 M 负债及股东权益总额 1.43 M10.49 M11.64 M7.75 M7.41 M7.61 M 总债务 18.9 K0———— 净债务 -1.11 M-9.84 M————

新闻

Silo Pharma股价因100万美元股份回购计划而飙升

Silo Pharma stock surges on $1M share buyback program

Silo Pharma授权100万美元股份回购计划

Silo Pharma authorizes $1 million stock buyback program

日本批准Silo Pharma创伤后应激障碍治疗药物专利

Japan grants patent for Silo Pharma’s PTSD treatment

Silo Pharma与Allucent签署意向书，开展SPC-15鼻喷剂临床试验

Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials

Silo Pharma首席执行官Weisblum购入公司价值$735股票

Silo Pharma CEO Weisblum buys $735 in company stock

Silo Pharma selects Allucent to support PTSD treatment IND submission

Silo Pharma selects Alphaledger T12 fund for blockchain asset investments